© John Wiley & Sons, Ltd.
Editors-in-Chief: Oliver Keene, Lisa LaVange and Gerd Rosenkranz
Impact Factor: 1.102
ISI Journal Citation Reports © Ranking: 2013: 45/119 (Statistics & Probability); 201/256 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Most cited papers from Pharmaceutical Statistics published in 2012 & 2013:
Quantitative comparison of randomization designs in sequential clinical trials based on treatment balance and allocation randomness
Zhao, Wenle; Weng, Yanqiu; Wu, Qi; et al.
A convenient formula for sample size calculations in clinical trials with multiple co-primary continuous endpoints
Sugimoto, Tomoyuki; Sozu, Takashi; Hamasaki, Toshimitsu
Investigating the assumption of homogeneity of treatment effects in clinical studies with application to meta-analysis
Julious, Steven A.; Whitehead, Anne
Additional results for 'Sequential design approaches for bioequivalence studies with crossover designs'
Montague, Timothy H.; Potvin, Diane; DiLiberti, Charles E.; et al.
Analysis of hypoglycemic events using negative binomial models
Luo, Junxiang; Qu, Yongming
Specifications of a continual reassessment method design for phase I trials of combined drugs
Wages, Nolan A.; Conaway, Mark R.
Attenuation of treatment effect due to measurement variability in assessment of progression-free survival
Hong, S.; Schmitt, N.; Stone, A.; et al.
Discounting phase 2 results when planning phase 3 clinical trials
Kirby, S.; Burke, J.; Chuang-Stein, C.; et al.
Extreme value modelling of laboratory safety data from clinical studies
Southworth, Harry; Heffernan, Janet E.
Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process models
Tang, Gong; Kong, Yuan; Chang, Chung-Chou Ho; et al.